Postoperative cognitive dysfunction after inhalational anesthesia in elderly patients undergoing major surgery: the influence of anesthetic technique, cerebral injury and systemic inflammation by unknown
RESEARCH ARTICLE Open Access
Postoperative cognitive dysfunction after
inhalational anesthesia in elderly patients
undergoing major surgery: the influence of
anesthetic technique, cerebral injury and
systemic inflammation
Yong Qiao1, Hao Feng1, Tao Zhao2, Heng Yan1, He Zhang1 and Xin Zhao1*
Abstract
Background: Elderly patients are reportedly at higher risk of postoperative cognitive dysfunction (POCD) after
inhalational anesthesia with sevoflurane. We hypothesized that the incidence of POCD would be higher in elderly
patients undergoing major surgery under inhalational rather than intravenous anesthesia. We also measured plasma
S-100β protein concentration as a biomarker of central nervous system injury, and plasma interleukin (IL)-6 and
tumor necrosis factor (TNF)-α concentrations to judge the contribution of systemic inflammation to POCD.
Methods: Ninety patients aged 65–75 years scheduled for resection of an esophageal carcinoma were randomly
assigned to one of three groups (n = 30) as follows: a group receiving sevoflurane anesthesia (Group S); a group
receiving preoperative methylprednisolone before sevoflurane anesthesia (Group S + MP); and a control group
maintained with intravenous propofol (Group C). The mini-mental state examination (MMSE) and Montreal
cognitive assessment (MoCA) were used to measure patients’ cognitive function the day before surgery, and on
the first, third and seventh postoperative days. The plasma concentrations of TNF-α, IL-6 and S-100β protein were
measured 10 min before anesthesia, and on the first, third and seventh postoperative days.
Results: There were no significant differences in the demographic or clinical characteristics, or perioperative
hemodynamic status, of the three groups. The MMSE and MoCA scores were significantly lower in Group S than in
the propofol control (Group C) and Group S + MP on the first, third and seventh postoperative days (P <0.05).
Throughout the first postoperative week the plasma concentrations of TNF-α, IL-6, and S-100β protein were
significantly elevated in Group S compared with Group C (P <0.05), but were significantly lower in Group S +MP
than Group S (P <0.05).
Conclusions: The incidence of POCD was higher in elderly patients undergoing major surgery under inhalational
anesthesia with sevoflurane than those maintained on intravenous propofol, and lower in elderly patients pro-treating
with methylprednisolone. Furthermore, we found elevated plasma concentrations of S-100β protein, TNF-α and IL-6 in
those receiving sevoflurane anesthesia.
Trial registration: ChiCTR-IOR-15007007 (02-09-2015).
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Background
Postoperative cognitive dysfunction (POCD) is charac-
terized by progressive hypomnesia, personality change
or deterioration in cognitive function after surgery [1].
The incidence of POCD is rising steadily in patients
undergoing general anesthesia [2, 3]. Age is the main
risk factor for POCD, and although it is well recognized
that the incidence of POCD is higher in the elderly [4],
particularly those undergoing sevoflurane anesthesia [5],
the mechanism is not fully understood.
There have been several reports that central nervous
system inflammation provoked by anesthesia and surgery
plays an important role in the pathogenesis of POCD
[6]. Anesthesia and surgery have been shown to increase
the brain concentration of interleukin (IL)-6, leading to
neuronal apoptosis [7], and to provoke the release of the
pro-inflammatory cytokine tumor necrosis factor (TNF)-α
[8]. S-100β protein is an acidic calcium-binding protein
found in the central nervous system, and when detected
in the systemic circulation is considered a biomarker of
acute brain injury [8, 9].
We undertook a randomized clinical trial to estab-
lish whether TNF-α, IL-6 or S-100β might play a
role in the pathogenesis of POCD in elderly patients
undergoing resection of an esophageal carcinoma
under sevoflurane anesthesia with or without preopera-
tive methylprednisolone, or under total intravenous
anesthesia with propofol. Identifying a relationship between
the serum concentrations of these pro-inflammatory cyto-
kines and markers of cerebral injury would be an important
step towards establishing strategies for the prevention of
POCD.
Methods
The study design was a prospective, double blind, ran-
domized, controlled trial. It was conducted at the Sec-
ond Affiliated Hospital of Shandong University, after
approval had been obtained from the ethics committee
of the Second Affiliated Hospital of Shandong University
(IRB protocol number: SDUEY20121118). Informed con-
sent was obtained from each participant.
Fig. 1 Comparison of HR (a), MAP (b), CVP (c), Time of breathing recovery, eyes opening, and extubation (d) in group C, group S, and group S +MP.
HR, MAP, CVP were recorded at the time of entering the operating room (T0), the time before tracheal intubation (T1), the time before operation (T2),
the time of the end of operation (T3), the time after tracheal extubation (T4) in group C, group S, and group S +MP. Compared with group C at
corresponding time point, #P > 0.05 in group S, *P > 0.05 in group S +MP. Compared with the time of breathing recovery, eyes opening, and
extubation in group C, #P > 0.05 in group S, *P > 0.05 in group S +MP. Data are representative of 30 independent experiments
Table 1 Clinical characteristics of patients
Group C Group S Group S +MP P-Value
Gender (n)
Male/Female
21/9 22/8 21/9 0.832*
Age (yr) 68 ± 2 68 ± 3 69 ± 3 0.705
Body Mass
Index (BMI)
24.41 ± 1.52 23.65 ± 1.14 24.24 ± 3.19 0.831
Preoperative
MMSE Scores
28.62 ± 1.14 27.83 ± 1.79 27.45 ± 1.14 0.408
Duration of
Surgery (min)
130 ± 5 128 ± 8 130 ± 5 0.786
Data are given as mean ± SD. *Fisher exact test
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Patients
Ninety patients aged between 65 and 75 years undergo-
ing esophageal carcinoma resection between January
2013 and December 2014 were enrolled. Patients were
randomly assigned to one of three groups (n = 30) as fol-
lows: a group receiving sevoflurane anesthesia (Group S); a
group receiving sevoflurane anesthesia after preoperative
treatment with methylprednisolone (Group S +MP); and a
control group of patients receiving intravenous propofol
anesthesia (Group C).
The inclusion criteria were: American Society of Anes-
thesiologists (ASA) physical status I, II or III; a sufficient
level of education to be capable of completing neuro-
psychological tests; a pre-operative mini mental state
examination (MMSE) score ≥23; no evidence of cardio-
vascular, respiratory or central nervous system disease;
normal renal and hepatic function; no serious hearing or
visual impairment; absence of a history of benzodiazep-
ine or antidepressant use, alcohol or cigarette misuse or
drug dependence; and no contraindication to propofol
or inhalational anesthesia.
Patient management
Anesthesia was managed according to a standardized
protocol that was identical for each group. Patients had
fasted for 8 h and abstained from water for 4 h pre-
operatively. Arterial blood pressure, heart rate (HR), the
electrocardiogram, peripheral blood oxygen saturation,
bispectral index (BIS), end tidal CO2 (PETCO2) and in-
ternal jugular central venous pressure were monitored in
the operating room and recorded every 5 min.
Following 3 min of pre-oxygenation (with 100 % O2),
anesthesia was induced by means of a single slow in-
travenous injection of midazolam (2–3 mg), etomidate
(0.3 mg/kg) and an infusion of sufentanil (0.4 μg/kg). Tra-
cheal intubation was facilitated with cisatracurium besy-
late (0.3 mg/kg). A left-sided double-lumen Robertshaw
endobronchial tube (diameter Fr 35–39) was positioned
using a laryngoscope.
Mechanical ventilation was initiated with a tidal volume
of 7 ml/kg, a respiratory rate of 12 /min, a positive end
expiratory pressure of 5 cmH2O and inspiratory–
Table 2 Emergence from anaesthesia
Group C Group S Group S + MP P-Value
Breathing recovery 9.2 ± 4.5 8.9 ± 4.2 8.1 ± 5.0 0.918
Eyes opening 16.4 ± 5.5 17.6 ± 6.2 16.2 ± 5.7 0.912
Extubation 20.2 ± 7.2 22.2 ± 8.1 21.6 ± 7.5 0.914
All times are given as mean ± SD
Fig. 2 Comparison of MMSE and MoCA scores, S-100β protein level in group C, group S, and group S +MP. MMSE and MoCA scores were used
to assess the cognitive function at the day before operation (Ts), the first (Tb), third (Tc), and seventh (Td) day after operation, and S-100β protein
level was used to reflect the level of brain injury at 10 min before anesthesia (Ta), the first (Tb), third (Tc), and seventh (Td) day after operation in
different groups. a and b: MMSE and MoCA scores in different groups. Compared with Group C at Tb, Tc, and Td, #P <0.05 in group S; Compared
with Group S at Tb, Tc, and Td, *P <0.05 in group S +MP. c: S-100β protein level in different groups. Compared with Group C at Tb, Tc, and Td,
#P <0.05 in group S; Compared with Group S at Tb, Tc, and Td, *P <0.05 in group S +MP. Data are representative of 30 independent experiments
Table 3 Comparison of the levels of MMSE in group C, group S,
and group S +MP
Group C Group S Group S +MP P1-Value P2-Value
Ts 28.16 ± 1.60 27.83 ± 1.94 28.33 ± 1.21 0.725 0.599
Tb 22.50 ± 2.26 19.17 ± 2.14 22.43 ± 2.43 0.023 0.023
Tc 24.67 ± 3.67 19.33 ± 3.83 25.67 ± 2.34 0.015 0.005
Td 26.67 ± 3.67 20.33 ± 3.39 27.33 ± 4.37 0.012 0.006
Data are given as mean ± SD. P1-Value, group S versus group C (LSD). P2-Value,
group S +MP versus group S (LSD)
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expiratory ratio of 1:2 to maintain PETCO2 in the range
35–40 mmHg. Oxygen flow rate was set at 2 l/min.
Anesthesia was maintained in Group C by propofol ad-
ministered by target controlled infusion (effect site concen-
tration 4 ug/ml) and 1 minimum alveolar concentration
(MAC) sevoflurane in Groups S and group S +MP. Intra-
venous infusion of methylprednisolone (10 mg/kg) was ad-
ministered 30 min before anesthesia to patients in Group
S +MP. Maintenance of anesthesia was supplemented by
an intravenous infusion of remifentanil (commenced at
0.15 μg/kg/min and titrated according to clinical need).
The sevoflurane or propofol was titrated on the basis of
hemodynamic parameters (HR, systolic arterial blood pres-
sure), to maintain BIS in the range 50–60, and if somatic
(swallowing, movement) or autonomic signs (flushing,
sweating, salivating) were evident. A 5-mg bolus of cisatra-
curium besylate was administered every 30 min according
to clinical need. Sevoflurane and propofol were discontin-
ued at the start of suturing.
Intravenous crystalloids were administered (0.9 % NaCl
solution supplemented by lactated Ringer’s solution at a
ratio of 3:1) at an infusion rate of 0.5–1.0 ml/kg/min for
20–40 min followed by an infusion rate of 0.25 ml/kg min
to maintain a positive daily fluid balance and adequate
urine output.
Postoperative analgesia (PCA: sufentanil 2 ug/kg) was
provided using a patient-controlled intravenous tech-
nique for the first 72 h, with the following settings:
2 ml/h background infusion; 0.5-ml bolus, and a 15-min
lockout.
Patients’ demographic and basic clinical characteristics,
fluid balance, blood loss, duration of surgery, duration of
single lung ventilation, temperature, time taken for recov-
ery of spontaneous breathing, eye opening on command
and time taken for extubation were also recorded. We
recorded HR, mean arterial pressure (MAP) and central
venous pressure at five perioperative time points: on en-
tering the operating room (T0); before tracheal intubation
(T1); before surgery (T2); immediately after surgery (T3)
and immediately after tracheal extubation (T4).
Enzyme-linked immunosorbent assay (ELISA)
Blood specimens were collected from the patients 10 min
before anesthesia (Ta), and on the first (Tb), third (Tc),
and seventh (Td) postoperative days. Plasma was obtained
by centrifugation at 4000 × g for 20 min at 4 °C and stored
at–80 °C. The concentrations of IL-6, TNF-α and S100β
protein were measured using an ELISA kit according to
the manufacturer’s instructions.
Assessment of perioperative cognitive function
The MMSE and Montreal Cognitive Assessment (MoCA)
were used to assess cognitive function the day before
surgery (Ts), and on the first (Tb), third (Tc) and seventh
(Td) postoperative days. All data collectors had undergone
standard training, and were blinded to the randomization
status of the participants. The MMSE consists of tests of
orientation (in time and place), memory (immediate and
short-term), calculation, language (naming, repetition, lis-
tening and reading comprehension, writing), visual spatial
awareness, concentration and attention, and is suitable for
detecting more severe cognitive dysfunction. The MoCA
tests visuospatial and executive function (alternate trail
making test, copy the cube, clock drawing), language abil-
ity, attention and calculation, delayed recall and abstract
thinking, and can detect milder cognitive dysfunction. Pa-
tients’ cognitive function was evaluated by MoCA if the
MMSE score equaled or exceeded 20.
Statistical analysis
Assays were performed in triplicate, and representative
examples of at least one assay are shown. All data are
expressed as mean ± standard deviation (SD). Statistical
differences were assessed using one-way analysis of vari-
ance (ANOVA) with the least significant difference (LSD)
post hoc tests. A P value <0.05 was considered statistically
significant. All statistical analyses were performed using
the SPSS 19.0 statistics program for windows (SPSS, IBM,
USA).
Table 4 Comparison of the levels of MoCA in group C, group S,
and group S +MP
Group C Group S Group S +MP P1-Value P2-Value
Ts 27.55 ± 4.58 26.90 ± 3.83 25.95 ± 2.61 0.769 0.684
Tb 20.33 ± 2.34 15.33 ± 2.58 21.48 ± 2.43 0.003 0.001
Tc 23.83 ± 3.87 17.83 ± 2.99 24.33 ± 3.33 0.008 0.005
Td 25.33 ± 4.89 18.01 ± 4.15 27.67 ± 4.41 0.013 0.002
Data are given as mean ± SD. P1-Value, group S versus group C (LSD). P2-Value,
group S +MP versus group S (LSD)
Table 5 Comparison of the levels of S100 β in group C, group S, and group S + MP
Group C Group S Group S + MP P1-Value P2-Value
Ta 1043.42 ± 20.73 1028.45 ± 28.73 1038.61 ± 26.65 0.327 0.503
Tb 1864.93 ± 50.51 2194.28 ± 63.72 1728.87 ± 40.31 0.000 0.000
Tc 1562.37 ± 48.08 1836.55 ± 52.37 1576.73 ± 58.59 0.000 0.000
Td 1328.83 ± 38.22 1531.60 ± 42.83 1261.50 ± 50.15 0.000 0.000
Data are given as mean ± SD. P1-Value, group S versus group C (LSD). P2-Value, group S +MP versus group S (LSD)
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Results
Participants’ demographic and clinical characteristics
There were no significant differences between the
groups in terms of gender, age, body mass index (BMI)
or preoperative MMSE scores (Table 1), nor were there
significant differences in perioperative hemodynamic pa-
rameters (Fig. 1a, b, c), time to recovery of spontaneous
breathing, emergence from anesthesia or time to extuba-
tion (Fig. 1d; Table 2).
Cognitive function assessment and plasma S-100β
concentration
The MMSE and MoCA scores on the first, third and sev-
enth postoperative days were significantly lower in Group S
than controls (P <0.05; Fig. 2a, b; Tables 3 and 4). Further-
more, the MMSE and MoCA scores on the first, third and
seventh postoperative days were significantly higher in
Group S +MP than Group S (P <0.05; Fig. 2a, b; Tables 3
and 4). The concentration of plasma S-100β protein was
significantly higher in Group S than Group C and Group S
+MP at all postoperative time points (P <0.05; Fig. 2c;
Table 5).
Plasma IL-6 and TNF-α concentrations
The plasma concentrations of IL-6 and TNF-α were sig-
nificantly higher in Group S on the first, third and seventh
postoperative days than controls (P <0.05; Fig. 3a, b;
Tables 6 and 7), and were significantly lower in group S
than those in Group S +MP (P <0.05; Fig. 3a, b;
Tables 6 and 7) at each time point.
Discussion
We found that the incidence of POCD in elderly pa-
tients undergoing major surgery was higher in those
receiving sevoflurane general anesthesia than those
receiving total intravenous anesthesia with propofol.
We also found that methylprednisolone afforded a de-
gree of neuroprotection in those receiving sevoflurane
anesthesia, and that POCD was associated with ele-
vated postoperative plasma concentrations of TNF-α,
IL-6 and S100β protein.
Postoperative cognitive dysfunction may be manifest
as impairment of working memory, long-term memory,
information processing, attention or cognitive flexibility
[10], adversely affecting quality of life, social independ-
ence and mortality [11]. It may persist for weeks or
months, and may not resolve at all in a small proportion
of those affected [12].
Inhalational anesthetic drugs are reported to promote
neuronal apoptosis in animal models, leading to a decline
in learning ability and memory after anesthesia [13–15].
Uemura et al. documented behavioral abnormalities in
Fig. 3 Comparison of the levels of TNF-α, IL-6 in group C, group S, and group S +MP. The levels of TNF-α, IL-6 were used to reflect the systemic
inflammatory response at 10 min before anesthesia (Ta), the first (Tb), third (Tc), and seventh (Td) day after operation in group C, group S, and
group S +MP. a: the level of TNF-α in different groups. Compared with Group C at Tb, Tc, and Td, #P <0.05 in group S; Compared with Group S
at Tb, Tc, and Td, *P <0.05 in group S +MP. b: the level of IL-6 in different groups. Compared with Group C at Tb, Tc, and Td, #P <0.05 in group S;
Compared with Group S at Tb, Tc, and Td, *P <0.05 in group S +MP. Data are representative of 30 independent experiments
Table 6 Comparison of the levels of IL-6 in group C, group S,
and group S +MP
Group C Group S Group S +MP P1-Value P2-Value
Ta 44.33 ± 4.41 43.25 ± 5.40 44.52 ± 4.79 0.707 0.664
Tb 95.40 ± 5.31 122.23 ± 6.85 80.48 ± 7.71 0.000 0.000
Tc 78.75 ± 5.98 92.11 ± 4.26 71.32 ± 6.18 0.001 0.000
Td 63.58 ± 6.33 78.43 ± 6.95 55.42 ± 5.82 0.001 0.000
Data are given as mean ± SD. P1-Value, group S versus group C (LSD). P2-Value,
group S +MP versus group S (LSD)
Table 7 Comparison of the levels of TNF-α in group C, group S,
and group S +MP
Group C Group S Group S +MP P1-Value P2-Value
Ta 26.37 ± 4.73 25.65 ± 5.62 25.68 ± 4.56 0.807 0.991
Tb 38.41 ± 5.13 48.82 ± 6.89 36.43 ± 4.27 0.005 0.002
Tc 32.92 ± 3.16 42.63 ± 3.87 33.83 ± 4.54 0.001 0.001
Td 28.92 ± 3.90 37.65 ± 4.84 29.80 ± 4.28 0.003 0.007
Data are given as mean ± SD. P1-Value, group S versus group C (LSD). P2-Value,
group S +MP versus group S (LSD)
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adult rats that had been exposed to halothane in utero
[16]. Exposure to a low concentration of halothane or
N2O reportedly causes visual impairment, and reduces in-
stantaneous memory, and athletic and cognitive abilities
[17]. Post-exposure cognitive function is also reportedly
superior in patients anesthetized with intravenous propo-
fol than those treated with sevoflurane [18].
Our findings are consistent with this body of research.
We documented a substantial reduction in MMSE and
MoCA scores in the first postoperative week in those ex-
posed to sevoflurane rather than propofol. This suggests
that sevoflurane increases the risk of POCD in elderly
patients undergoing major surgery.
The presence of S100β protein in the systemic circula-
tion is an indicator of central nervous system injury. With
increasing age, ongoing demyelination leads to an increase
in the plasma concentration and half-life of S-100β pro-
tein [19]. The physiological role of S100β protein, which is
produced by astrocytes, is to enhance interaction between
neurons and glial cells [20]. An increased concentration of
S100β protein is indicative of a severe brain injury [21].
We found that the plasma concentration of S100β protein
was significantly more elevated throughout the first post-
operative week in those anesthetized with sevoflurane
compared with those who received propofol. This suggests
that plasma S100β protein concentration could be used as
a biomarker of POCD.
In the elderly, POCD may persist for weeks or months
after inhalational anesthesia and a small minority of
patients is affected for longer; however, the pathophysio-
logic mechanisms are still not fully understood. Propofol
is reported to inhibit the activation and release of inflam-
matory factors such as IL-6 and TNF-α by astrocytes in
the central nervous system [22, 23]. This implicates IL-6
and TNF-α in the pathogenesis of POCD caused by
sevoflurane.
Interleukin-6 is an important regulator of synapse for-
mation; a high local concentration of IL-6 is reported to
inhibit synaptic function. Hippocampal neurogenesis in
the dentate gyrus is reported to be decreased by 63 % in
adult transgenic rats that overexpress IL-6 from their as-
trocytes [24]. Administration of a neutralizing antibody
for IL-6 also significantly improves long-term potenti-
ation (LTP) and spatial memory in rats. The influence of
IL-6 on the generation of LTP, and its inhibitory effects
on learning and memory, suggest it is likely to also play
a role in POCD [25].
Tumor necrosis factor-α is a cell signaling protein
involved in innate and specific immunity, and promotes the
inflammatory response [26, 27]. Monocytes and macro-
phages activated by external stimuli release TNF-α, which
in turn promotes the release of other inflammatory media-
tors and pro-inflammatory cytokines such as IL-6, thus
starting the inflammatory cascade reaction. Isoflurane
anesthesia is reported to increase the incidence of
POCD in diabetic rats by a TNF-α–dependent mech-
anism [28].
We found that the plasma concentrations of IL-6 and
TNF-α were significantly higher throughout the first
postoperative week in those exposed to sevoflurane than
propofol. Furthermore, the plasma concentrations of IL-6
and TNF-α were significantly lower in those undergoing
sevoflurane anesthesia if they had been administered
methylprednisolone preoperatively. This suggests that the
pro-inflammatory cytokines IL-6 and TNF-α may be part
of the mechanism underlying the pathophysiology of
POCD in elderly patients undergoing major surgery.
Methylprednisolone (10 ug/mL) could suppress lympho-
cyte blastoid transformation, immunoglobulin production,
and inflammatory action [29]. This study showed that pre-
operative methylprednisolone administration suppressed
postoperative increases in the plasma levels of IL-6 and
TNF-α. Methylprednisolone may be an effective means of
reducing the incidence of POCD in elderly patients caused
by sevoflurane inhalation anesthesia by suppressing the
level of IL-6 and TNF-α.
We found a higher incidence of POCD in patients
undergoing major surgery under sevoflurane anesthesia,
and an association with increased plasma concentrations
of IL-6 and TNF-α. Preoperative treatment with methyl-
prednisolone may afford a degree of protection against
POCD, raising the possibility that it could be used prophy-
lactically in elderly patients undergoing major surgery.
Conclusions
We found that the incidence of POCD was higher in pa-
tients undergoing sevoflurane anesthesia for major surgery
than those receiving an intravenous propofol regime, and
lower in elderly patients pro-treating with methylprednis-
olone. The MMSE and MoCA were useful tools for the
detection of POCD, and plasma S-100β protein concen-
tration may be a useful biomarker of disease. Furthermore,
POCD was associated with elevated plasma concentra-
tions of IL-6 and TNF-α.
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